A Case Study of Atrial Fibrillation Induced by Utidelone in Palliative Chemotherapy for Metastatic Breast Cancer - Top-Institutions - MDSpire

A Case Study of Atrial Fibrillation Induced by Utidelone in Palliative Chemotherapy for Metastatic Breast Cancer

  • By

  • Qihuan Shen

  • Yuhao Huang

  • Haoran Li

  • Baoying Chen

  • Huadi Shi

  • Zumin Xu

  • April 29, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Oncology
    • Cardio-Oncology
    • Breast Cancer Research

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Oncology
    • Cardio-Oncology
    • Breast Cancer

  • #3

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Oncology
    • Cardio-Oncology
    • Breast Cancer

  • #4

    Fudan University Shanghai Cancer Center
    Fudan University Shanghai Cancer Center

    Shanghai, Shanghai

    Key Differentiators

    • Oncology
    • Breast Cancer
    • Pharmacology

  • #5

    Johns Hopkins Medicine
    Johns Hopkins Medicine

    Baltimore, MD

    Key Differentiators

    • Oncology
    • Cardiology
    • Cardio-Oncology

Original Source(s)

A Case Study of Atrial Fibrillation Induced by Utidelone in Palliative Chemotherapy for Metastatic Breast Cancer

  • by Qihuan Shen, Yuhao Huang, Haoran Li, Baoying Chen, Huadi Shi, Zumin Xu

  • April 29, 2026

Related Content

Case Report: [225Ac]Ac-PSMA-617 therapy in a patient with metastatic castration-resistant prostate cancer (mCRPC) and intracranial meningioma

Diffuse large B-cell lymphoma presenting as a scalp tumor with skull destruction and neurological symptoms: a case report

Stimuli-responsive nanoplatforms for sonodynamic immunotherapy: opportunities and challenges in cancer treatment